The global nootropics market size is expected to reach USD 11.48 billion by 2033, registering a CAGR of 9.1% from 2026 to 2033, according to a new report by Grand View Research, Inc. The global market has witnessed increased growth in the last few years, which is expected to continue over the forecast period. This growth is driven by the increasing awareness among consumers regarding the cognitive health benefits of nootropics and their desire to improve mental performance. As the global population ages, there is a growing interest in products that support brain health, and nootropics are seen as a viable option. In addition, the prevalence of stress and mental health concerns is propelling individuals to explore cognitive enhancers.
Nootropic capsules have higher penetration as they are easy to take and do not require any preparation or mixing. Consumers can simply swallow a capsule with water, making it a convenient option for those with busy lifestyles. Capsules provide precise and consistent dosages of nootropic ingredients. This is particularly important when it comes to cognitive enhancers, as accurate dosing is crucial for achieving the desired effects. Capsules are a common form of pharmaceuticals and dietary supplements, which can enhance the perceived credibility of nootropic products.
Nootropics manufacturers are increasingly prioritizing natural ingredients in response to the growing consumer demand for such products. For instance, in October 2021, XITE, a nootropic energy drinks brand, launched a nootropic vegan protein bar to appeal to the growing consumer base of mind health-conscious consumers. The bars are packed with nootropics, such as caffeine, L-theanine, and ashwagandha, which are claimed to improve cognitive function, focus, and energy level. Similarly, in April 2019, Gaia Herbs launched new vegan supplements called Bacopa made using Bacopa; Nootropic Focus made with saffron, lemon balm, and spearmint; and Agile Mind made with Bacopa, gingko, and turmeric.
Request a free sample copy or view report summary: Nootropics Market Report
The nootropics industry has seen a significant surge in interest over recent years, driven by a growing consumer focus on cognitive enhancement and overall mental well-being.
Capsule/ tablets nootropics accounted for a share of 48.8% in the global market in 2025. Capsules offer consumers a convenient and precise way to deliver a consistent dose of nootropic ingredients.
The sales of nootropics through offline channels accounted for a 72.6% share in 2025. Traditional retail outlets like hypermarkets, supermarkets, pharmacies & drugstores
The online segment is expected to grow at a CAGR of 10.5% from 2026 to 2033. Online channels are time-saving when compared to visiting physical stores, providing a convenient way to order.
The North America nootropics market held a major share of 40.3% in 2025. The demand for nootropics in this region has increased, which can be attributed to the growing health and wellness trend.
Grand View Research has segmented the global nootropics market report on the basis of form, distribution channel, and region:
Nootropics Form Outlook (Revenue, USD Million, 2021 - 2033)
Capsules/Tablets
Powder
Drinks
Others
Nootropics Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
Offline
Online
Nootropics Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Asia Pacific
China
India
Japan
Australia & New Zealand
South Korea
Central & South America
Brazil
Middle East & Africa
UAE
List of Key Players in the Nootropics Market
Onnit Labs, Inc.
Reckitt Benckiser Group PLC
Mental Mojo, LLC
NooCube
Mind Lab Pro (Performance Lab Group Ltd)
TruBrain
Neu Mind, LLC
Nooflux LLC
Zhou Nutrition
Kimera Koffee
"The quality of research they have done for us has been excellent..."